Sirolimus in Preventing Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
This study is currently recruiting participants.
Study NCT00077480
Information provided by National Cancer Institute (NCI)
First Received: February 10, 2004
Last Updated: October 10, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
